[1]
“A two-year retrospective observational study of adverse drug reactions related to intravenous drug formulations”, jpadr, vol. 2, no. 1, pp. 22–26, Mar. 2021, Accessed: Oct. 13, 2026. [Online]. Available: https://test.jpadr.com/index.php/jpadr/article/view/19